Cassava Sciences, Inc.
SAVA
$2.18
$0.041.87%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -62.56% | -33.43% | |||
| Gross Profit | 62.56% | 33.43% | |||
| SG&A Expenses | 13.33% | 939.87% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -34.72% | 10.21% | |||
| Operating Income | 34.72% | -10.21% | |||
| Income Before Tax | -88.97% | 15.20% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -88.97% | 15.20% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -88.97% | 15.20% | |||
| EBIT | 34.72% | -10.21% | |||
| EBITDA | 35.07% | -10.55% | |||
| EPS Basic | -88.80% | 15.49% | |||
| Normalized Basic EPS | 36.71% | -14.87% | |||
| EPS Diluted | -89.73% | 15.49% | |||
| Normalized Diluted EPS | 36.71% | -14.87% | |||
| Average Basic Shares Outstanding | 0.10% | 0.34% | |||
| Average Diluted Shares Outstanding | 0.10% | 0.34% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||